Position in GSK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$242,914
-$3,024,554 QoQ
Shares Held
4,634
-92.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#658
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADVISORS MANAGEMENT GROUP INC /ADV holds $7,828,853 across 8 Drug Manufacturers - General names. GSK ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,144 | $5,623,911 | |
| 2 | AZN |
Astrazeneca PLC
|
2,355 | $446,555 | |
| 3 | NVS |
Novartis AG
|
2,167 | $339,612 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,579 | $331,401 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,643 | $325,149 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,521 | $318,503 | |
| 7 | GSK |
GSK plc
This page
|
4,634 | $242,914 | |
| 8 | ABBV |
AbbVie Inc.
|
798 | $200,808 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,914 | 4,634 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,267,468 | 59,204 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,633,373 | 74,090 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $3,820,695 | 88,524 | Shares | Sole | 2025-12-18 | |
| 2025-06-30 | $3,457,574 | 90,041 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $3,532,545 | 91,186 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $3,095,544 | 91,530 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,526,758 | 86,271 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $3,174,209 | 82,447 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $3,492,018 | 81,456 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,047,147 | 82,222 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,991,205 | 82,516 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,880,781 | 80,830 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,775,275 | 78,001 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $2,509,944 | 71,427 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $2,093,238 | 71,126 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $2,880,109 | 67,459 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $2,888,289 | 67,604 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,922,926 | 67,577 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $2,543,745 | 67,876 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $2,704,941 | 69,259 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $2,431,045 | 69,449 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $2,532,496 | 70,165 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $2,601,489 | 70,468 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $2,837,124 | 70,916 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $2,693,130 | 72,469 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||